Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millan

Showing results (281-290 of 496) with videos related to

Pageof 50
Sort By:
British Journal of Pharmacology|November 11, 1999
Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmissionC Sebban, X Q Zhang, B Tesolin-Decros, et al.
Brain Research|March 16, 1981
Stress-induced release of brain and pituitary beta-endorphin: major role of endorphins in generation of hyperthermia, not analgesiaM J Millan, R Przewłocki, M Jerlicz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 17, 2008
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugsZaorui Zhao, Han-Ting Zhang, Elianna Bootzin, et al.
Neuropharmacology|December 21, 2006
Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonistsC Mannoury la Cour, S Vidal, V Pasteau, et al.
European Journal of Pharmacology|November 24, 1994
Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297J M Rivet, V Audinot, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonistsM J Millan, J M Rivet, H Canton, et al.
Bioorganic & Medicinal Chemistry Letters|March 28, 2009
Modulations of the amide function of the preferential dopamine D3 agonist (R,R)-S32504: improvements of affinity and selectivity for D3 versus D2 receptorsJean-Louis Peglion, Christophe Poitevin, Clotilde Mannoury La Cour, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigmM J Millan, J M Rivet, A Gobert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2021
Evidence for Prescribed NK Cell Ly-49 Developmental Pathways in MiceAlberto J Millan, Bryan A Hom, Jeremy B Libang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626M J Millan, A Dekeyne, J M Rivet, et al.
Pageof 50

Showing results (281-290 of 496) with videos related to

Sort By:
Pageof 50
British Journal of Pharmacology|November 11, 1999
Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmissionC Sebban, X Q Zhang, B Tesolin-Decros, et al.
Brain Research|March 16, 1981
Stress-induced release of brain and pituitary beta-endorphin: major role of endorphins in generation of hyperthermia, not analgesiaM J Millan, R Przewłocki, M Jerlicz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 17, 2008
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugsZaorui Zhao, Han-Ting Zhang, Elianna Bootzin, et al.
Neuropharmacology|December 21, 2006
Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonistsC Mannoury la Cour, S Vidal, V Pasteau, et al.
European Journal of Pharmacology|November 24, 1994
Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297J M Rivet, V Audinot, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonistsM J Millan, J M Rivet, H Canton, et al.
Bioorganic & Medicinal Chemistry Letters|March 28, 2009
Modulations of the amide function of the preferential dopamine D3 agonist (R,R)-S32504: improvements of affinity and selectivity for D3 versus D2 receptorsJean-Louis Peglion, Christophe Poitevin, Clotilde Mannoury La Cour, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigmM J Millan, J M Rivet, A Gobert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2021
Evidence for Prescribed NK Cell Ly-49 Developmental Pathways in MiceAlberto J Millan, Bryan A Hom, Jeremy B Libang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626M J Millan, A Dekeyne, J M Rivet, et al.
Pageof 50